spacer
home > ict > spring 2006 > everybody wins
PUBLICATIONS
International Clinical Trials

Everybody Wins

Providing sites with the communication tools to engage and retain patients is crucial contend Janet Jones at Kendle and Val Lyness at ICR, as they explore holistic approaches to patient-centric recruitment and retention

“What’s in it for me?” Nine times out of 10, it’s the first thing a patient will think about when considering whether or not to participate in a clinical study. As an industry, we’re well aware of this, but are we giving patients the right answers? Are we approaching patient recruitment and retention in the best way possible?

WHAT HAPPENS WHEN THE SITE’S DATABASE IS EXHAUSTED?

There are several steps that can be considered when a site’s database has become exhausted, such as referrals from colleagues, the involvement of advocacy or patient support groups, community outreach with flyers and mailings and direct-to-patient communications. Recruitment planning needs to be considered at several levels ranging from providing siteby- site recruitment plans through to conducting a full directto- patient media campaign.

Sites need to be encouraged to start thinking about the next contingency plan early in the process, not when the failure to recruit has become a major issue. CRAs and the project team can help the sites to develop specific recruitment plans, and to constantly think about the next step and how to overcome recruitment barriers.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer

Dr Janet Jones, Director of Global Patient Access and Retention, joined Kendle in 2000 and has overall responsibility for Kendle’s integrated patient recruitment and retention programs. With more than 20 years’ experience in clinical research, she has gained a wealth of industry expertise as a CRA, lead CRA and project manager. Janet is a widely-published molecular geneticist and patient recruitment and retention expert, with a doctorate in molecular biology.

Val Lyness is a leading figure within the Institute of Clinical Research (ICR) having been Chairman of the Board from 1997 until 2000. She is an active member of the ICR Advisory Group that provides guidance to ICR on consultations and current issues. As one of the longest-serving members, she is now an Honorary Fellow of the ICR with more than 20 years’ experience as a clinical research professional.

spacer
Janet Jones
spacer
spacer
spacer
Val Lyness
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement